FDA Approves AstraZeneca's Ultomiris for Neuromyelitis Optica Spectrum Disorder

Common adverse effects of the treatment included COVID-19, headache, back pain, arthralgia and urinary tract infection. ^1-3. “Just four years since …
Source: back pain